Skip to main content

Animations

MJFF Publications

2501 - 2510 of 6403 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2025
  • 2021
  • 2021
  • 2020
  • 2021
  • 2024
  • 2023
  • Summary Details
    OPEN
    Title: Public Engagement and Neurology: An Update
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci11040429
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Hippocampal and Hippocampal-Subfield Volumes From Early-Onset Major Depression and Bipolar Disorder to Cognitive Decline
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2021.626974
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
    Journal Name: Trials
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13063-021-05273-x
    Citation Count: 33
  • Summary Details
    OPEN
    Title: N2GNet tracks gait performance from subthalamic neural signals in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-024-01364-6
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01199-2
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.cell.2021.03.048
    Citation Count: 265
  • Summary Details
    OPEN
    Title: Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-020-00220-5
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-021-00246-3
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer
    Journal Name: Nature Metabolism
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42255-024-01118-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Inhibition of striatal dopamine release by the L‐type calcium channel inhibitor isradipine co‐varies with risk factors for Parkinson's
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16180
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.